Limits...
What the public knows and wants to know about medicines research and development: a survey of the general public in six European countries.

Parsons S, Starling B, Mullan-Jensen C, Tham SG, Warner K, Wever K, Needs Assessment work package of European Patients' Academy on Therapeutic Innovation (EUPATI) Proje - BMJ Open (2015)

Bottom Line: Males were more likely than females to report good knowledge (17% vs 15%), and knowledge appeared to decrease with age.Some groups may need to be specifically targeted to increase their awareness of medicines R&D, for example, women expressed great interest in learning more but reported less knowledge than men.It may be useful to explore further the views of those who are currently uninterested in learning more.

View Article: PubMed Central - PubMed

Affiliation: Public Programmes Team, Central Manchester University Hospitals NHS Foundation Trust & University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Show MeSH
Relationship between interest in learning more about medicines R&D and gender, N=6931 (HTA, health technology assessment).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4390719&req=5

BMJOPEN2014006420F1: Relationship between interest in learning more about medicines R&D and gender, N=6931 (HTA, health technology assessment).

Mentions: Women expressed greater interest in learning more about all aspects of medicines R&D than men (figure 1). This difference was significant for all aspects. However, the areas of interest for men and women followed the same pattern with both being most interested in learning more about medicines safety and least interested in pharmacoeconomics.


What the public knows and wants to know about medicines research and development: a survey of the general public in six European countries.

Parsons S, Starling B, Mullan-Jensen C, Tham SG, Warner K, Wever K, Needs Assessment work package of European Patients' Academy on Therapeutic Innovation (EUPATI) Proje - BMJ Open (2015)

Relationship between interest in learning more about medicines R&D and gender, N=6931 (HTA, health technology assessment).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4390719&req=5

BMJOPEN2014006420F1: Relationship between interest in learning more about medicines R&D and gender, N=6931 (HTA, health technology assessment).
Mentions: Women expressed greater interest in learning more about all aspects of medicines R&D than men (figure 1). This difference was significant for all aspects. However, the areas of interest for men and women followed the same pattern with both being most interested in learning more about medicines safety and least interested in pharmacoeconomics.

Bottom Line: Males were more likely than females to report good knowledge (17% vs 15%), and knowledge appeared to decrease with age.Some groups may need to be specifically targeted to increase their awareness of medicines R&D, for example, women expressed great interest in learning more but reported less knowledge than men.It may be useful to explore further the views of those who are currently uninterested in learning more.

View Article: PubMed Central - PubMed

Affiliation: Public Programmes Team, Central Manchester University Hospitals NHS Foundation Trust & University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Show MeSH